CClinicalTrials.gg
CompletedNCT02563912Updated Apr 6, 2016

Pre-calculated Doses of Medication for Pediatric Resuscitation, a Simulation Experimental Trial

An interventional study of Handbook and Medication chart in Healthy, sponsored by St. Justine's Hospital. Completed at 1 site in Canada. Per ClinicalTrials.gov, last updated 2016-04-06.

Sponsored by St. Justine's Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Sex
All
01

Study summary

Dosage errors are common in the stressful situation of a pediatric resuscitation. In addition to that, studies have reported that delays to provide medication is associated to worst survival rate for very sick children. To minimize delays and error, the investigators recently published a resuscitation handbook who provides drug dosages for each weight for children thus eliminating the need for dosage calculation. Once the weight of the patient is known, the physicians only have to open the book at the page corresponding to the weight and all the medications with their calculated dosage are provided. The primary goal of this study is to evaluate the number of dosage error during simulated pediatric resuscitation comparing residents using the handbook vs. utilisation of a chart providing non-calculated dosage. This will be an experimental crossover trial among 40 residents performing four simulated case-scenarios in a high-fidelity simulation lab.

02

Conditions studied

  • Healthy

Keywords

  • Children
  • resuscitation
  • simulation
  • medication error
03

In context

Lead sponsor

St. Justine's Hospital is the lead sponsor of 155 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Residents doing a rotation in pediatrics emergency medicine

Exclusion criteria

Exclusion Criteria:

  • Resident who participated in a previous month
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Handbook

    Resuscitation handbook who provides drug dosages for each weight for children. For example, at the page of 15 kg, it is written that the dosage of epinephrin is 1.5 cc of 1: 10 000.

    Other: Handbook

  • Active comparator
    Medication chart

    Medication chart who provides drug dosages for each weight for children. For example,it is written that the dosage of epinephrin is 0.01 mg/kg.

    Other: Medication chart

Interventions

  • OtherHandbook

    Resuscitation handbook who provides drug dosages for each weight for children. For example, at the page of 15 kg, it is written that the dosage of epinephrin is 1.5 cc of 1: 10 000.

  • OtherMedication chart

    Medication chart who provides drug dosages for each weight for children. For example,it is written that the dosage of epinephrin is 0.01 mg/kg.

06

What researchers measure

Primary outcomes

  1. Having at least one dosage error in any of the medications during the case for a participant

    Difference of \> 10% of the recommended drug dosage for any of the medication provided during the simulated case scenario. To be perfect, there must be no error among all drugs provided.

    Time frame: During the simulation (10 minutes)

Secondary outcomes

  1. Dosage error in any for all individual medications during the case for a participant

    Difference of \> 10% of the recommended drug dosage for any of the medication provided during the simulated case scenario

    Time frame: During the simulation (10 minutes)

  2. Time for first drug prescription for each case per participant

    Time required for the prescription of the first dose of medication. From beginning of the case until the first dose of epinephrine is completely prescribed (Dosage included)

    Time frame: During the simulation (10 minutes)

07

Study locations

1 site
  • CHU Sainte-Justine
    Montreal, Quebec H3T1C5, Canada
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02563912
Lead sponsor
St. Justine's Hospital
Responsible party
Jocelyn Gravel (MD, MSc, FRCPC, St. Justine's Hospital) — Principal investigator
First posted
Sep 30, 2015
Start date
Sep 2015
Primary completion
Mar 2016
Completion
Mar 2016
Last update
Apr 6, 2016

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion